Qynapse - The future of neuroimaging is here
  • WHY QYNAPSE
  • I AM
    • Patient or Caregiver
    • Healthcare Provider
    • Pharma
    • Payer
  • PRODUCTS
    • QyScore®
    • QyPredict®
  • COMPANY
    • Team
    • Careers
  • NEWS
    • News & Press Releases
    • Publications
  • CONTACT
Select Page
University of Miami using Qynapse’s AI technology to research effects of Covid-19 on neuroimaging markers of cognitive impairment

University of Miami using Qynapse’s AI technology to research effects of Covid-19 on neuroimaging markers of cognitive impairment

by Administrators Qynapse | Sep 7, 2022 | Featured, News

BOSTON, MA, September 07, 2022 –  Qynapse Inc., a medical technology company with a commercialized Artificial Intelligence (AI) powered neuroimaging analysis platform for central nervous system (CNS) disorders, is pleased to announce a collaborative project with...
Qynapse Presenting 4 Posters on the Value and Utility of QyScore® at AAIC 2022

Qynapse Presenting 4 Posters on the Value and Utility of QyScore® at AAIC 2022

by Administrators Qynapse | Aug 1, 2022 | News, Updates

We are excited to announce that 4 posters demonstrating the value and utility of automated neuroimaging quantification tool QyScore® are being presented by our Scientific Director Elizabeth Gordon at Alzheimer’s Association International Conference (AAIC) 2022...
Qynapse and Calyx Partnering to Enable AI-enhanced Medical Imaging Services for CNS Clinical Trials

Qynapse and Calyx Partnering to Enable AI-enhanced Medical Imaging Services for CNS Clinical Trials

by Administrators Qynapse | Jul 25, 2022 | Featured, News

Nottingham, England, Morrisville, NC, and Boston, MA–July 25, 2022 – Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research and Qynapse, an Artificial Intelligence (AI) neuroimaging...
Qynapse to Present Symposium Oral and Poster presentations at AD/PD™ 2022 International Conference

Qynapse to Present Symposium Oral and Poster presentations at AD/PD™ 2022 International Conference

by Administrators Qynapse | Mar 3, 2022 | News

PARIS, FRANCE, March 3, 2022, PRNewswire – Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to announce that a symposium oral...
Qynapse to Present New Evidence on the Value of QyScore® for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022

Qynapse to Present New Evidence on the Value of QyScore® for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022

by Administrators Qynapse | Feb 14, 2022 | Featured, News

BOSTON, MA, February 14, 2022, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present 2 posters at the annual Americas Committee for...
Qynapse Unveils its New Brand and Latest Developments in Neuroimaging AI Innovation at the 2021 RSNA Meeting in Chicago

Qynapse Unveils its New Brand and Latest Developments in Neuroimaging AI Innovation at the 2021 RSNA Meeting in Chicago

by Administrators Qynapse | Nov 22, 2021 | News

BOSTON, MA, November 22, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an artificial intelligence (AI)-powered neuroimaging software platform for central nervous system (CNS) disorders, will unveil its new brand and latest AI...
« Older Entries

Careers

Qynapse Office Locations

Expanding Global Presence

Healthcare, Clinical Trial and Research Footprint

QYNAPSE (PARIS)
2-10 rue d’Oradour-sur-Glane
75015 Paris – France

QYNAPSE (BOSTON)
50 Milk St
Boston, MA, 02119 – USA

QYNAPSE (MONTREAL)
7240 Waverly St, Montreal,
Quebec H2R 2Y8 – Canada

contact@qynapse.com

  • Follow
  • Follow

Qynapse is ISO 13485, ISO/IEC27001 and HDS Certified, HIPAA Compliant, GDPR Compliant, and 21 C.F.R. Part 11 Compliant | QyScore® is FDA-Cleared, CE-Marked (CE2797) | Privacy Policy | ©2023 QYNAPSE ALL RIGHTS RESERVED. Last update: Jan 30. 2023

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT